These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 1797269)

  • 1. Use of the anti-PGL-I antibody ELISA and the Mitsuda reaction in early diagnosis of leprosy.
    Saad MH; Medeiros MA; Gallo ME; Fonseca LS
    Braz J Med Biol Res; 1991; 24(8):801-5. PubMed ID: 1797269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific anti-M leprae PGL-I antibodies and Mitsuda reaction in the management of household contacts in New Caledonia.
    Desforges S; Bobin P; Brethes B; Huerre M; Moreau JP; Bach MA
    Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):794-800. PubMed ID: 2681462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of anti-M. leprae phenolic glycolipid-I antibody detection for early diagnosis and prognosis of leprosy.
    Agis F; Schlich P; Cartel JL; Guidi C; Bach MA
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):527-35. PubMed ID: 3065419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between anti-PGL-I serology and Mitsuda reaction: clinical reading, microscopic findings and immunohistochemical analysis.
    Maeda SM; Rotta O; Michalany NS; Camargo ZP; Sunderkötter C; Tomimori-Yamashita J
    Lepr Rev; 2003 Sep; 74(3):263-74. PubMed ID: 14577472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between titers of antibodies immunoreacting against glycolipid antigens from Mycobacterium leprae and M. tuberculosis, the Mitsuda and Mantoux reactions, and bacteriological loads: implications in the pathogenesis, epidemiology and serodiagnosis of leprosy and tuberculosis.
    David HL; Papa F; Cruaud P; Berlie HC; Maroja MF; Salem JI; Costa MF
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):208-24. PubMed ID: 1522363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection by Mycobacterium leprae of household contacts of lepromatous leprosy patients from a post-elimination leprosy region of Colombia.
    Cardona-Castro NM; Restrepo-Jaramillo S; Gil de la Ossa M; Brennan PJ
    Mem Inst Oswaldo Cruz; 2005 Nov; 100(7):703-7. PubMed ID: 16410954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
    Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum IgA1 and IgM antibodies against Mycobacterium leprae-derived phenolic glycolipid-I: a comparative study in leprosy patients and their contacts.
    Chujor CS; Bernheimer H; Levis WR; Schwerer B
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):441-9. PubMed ID: 1890368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serodiagnosis of leprosy: relationships between antibodies to Mycobacterium leprae phenolic glycolipid I and protein antigens.
    Levis WR; Meeker HC; Schuller-Levis GB; Gillis TP; Marino LJ; Zabriskie J
    J Clin Microbiol; 1986 Dec; 24(6):917-21. PubMed ID: 3537003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological evidence of Toxoplasma gondii infection as potential risk for the development of lepromatous leprosy in an endemic area for both neglected tropical diseases in Brazil.
    Oliveira LRP; Martins LM; Souza RDC; Scheidegger de Castro Y; Nascimento LS; da Silva JA; Nahn Junior EP; da Silva WD; Peixoto-Rangel AL
    Infect Dis Poverty; 2020 Feb; 9(1):19. PubMed ID: 32051036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective immunological follow-up in household contacts of Mexican leprosy patients.
    Amezcua ME; Escobar-Gutiérrez A; Barba-Rubio J; Cázares JV; Mayén E; Chávez-Núñez M; Peña RC; Rodríguez R; Pastén S
    Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):651-9. PubMed ID: 2280115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
    Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Lipoarabinomannan-Specific Salivary IgA as Prognostic Marker for Leprosy Reactions in Patients and Cellular Immunity in Contacts.
    Nahas AA; Lima MIS; Goulart IMB; Goulart LR
    Front Immunol; 2018; 9():1205. PubMed ID: 29904387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dot-ELISA test for the detection of anti-PGL-1 IgM in leprosy patients and their contacts.
    Saad MH; Medeiros MA; Gallo ME; Gontijo-Filho PP; Fonseca LS
    Braz J Med Biol Res; 1991; 24(5):441-8. PubMed ID: 1823258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to a synthetic analog of phenolic glycolipid-I of Mycobacterium leprae in healthy household contacts of patients with leprosy.
    Menzel S; Harboe M; Bergsvik H; Brennan PJ
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):617-25. PubMed ID: 3323365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gelatin particle agglutination assay to detect anti-PGL-I antibodies in leprosy patients and in household contacts: a preliminary study.
    Mahajan P; Jogaikar DG; Jadhav VH; Mehta JM
    Indian J Lepr; 1992; 64(4):461-7. PubMed ID: 1308520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
    Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroepidemiological study on 724 household contacts of leprosy patients in French Polynesia using disaccharide-octyl-BSA as antigen.
    Chanteau S; Cartel JL; Guidi C; Plichart R; Bach MA
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):626-32. PubMed ID: 3323366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serologic responses to Mycobacterium leprae-specific phenolic glycolipid-I antigen in sooty mangabey monkeys with experimental leprosy.
    Gormus BJ; Ohashi DK; Ohkawa S; Walsh GP; Meyers WM; Brennan PJ; Trygg C
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):537-45. PubMed ID: 2464657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-PGL1 salivary IgA/IgM, serum IgG/IgM, and nasal Mycobacterium leprae DNA in individuals with household contact with leprosy.
    Brito e Cabral P; Júnior JE; de Macedo AC; Alves AR; Gonçalves TB; Brito e Cabral TC; Gondim AP; Pinto MI; Oseki KT; Camara LM; Rabenhorst SH; Nagao-Dias AT
    Int J Infect Dis; 2013 Nov; 17(11):e1005-10. PubMed ID: 23871279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.